Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)
NCT00144664 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 19
Last updated 2008-07-30
Summary
This is an open-label, Phase III study to evaluate the efficacy, safety and PK of MRA in patients with pJIA.
Conditions
- Systemic Juvenile Idiopathic Arthritis
Interventions
- DRUG
-
MRA(Tocilizumab)
Sponsors & Collaborators
-
Chugai Pharmaceutical
lead INDUSTRY
Principal Investigators
-
Takahiro Kakehi · Chugai Pharmaceutical
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 2 Years
- Max Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-11-30
- Primary Completion
- 2005-04-30
- Completion
- 2005-10-31
More Related Trials
-
Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)
NCT00144508 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA213JP
NCT00144534 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Treatment Study of MRA for Rheumatoid Arthritis (RA) From Study MRA012JP
NCT00144547 ·Status: COMPLETED ·Phase: PHASE3
-
PhaseⅢOpen-label Study of MRA for Rheumatoid Arthritis(RA)
NCT00380601 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)
NCT00642460 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)
NCT00144521 ·Status: COMPLETED ·Phase: PHASE3
-
Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)
NCT00144560 ·Status: COMPLETED ·Phase: NA
-
Clinical Pharmacology Study of MRA in Patient With Rheumatoid Arthritis (RA) With Renal Impairment
NCT00144573 ·Status: COMPLETED ·Phase: NA
-
A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)
NCT00661284 ·Status: COMPLETED
-
A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA
NCT03000439 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Subcutaneously (SC) Administered Tocilizumab (TCZ) in Participants With Polyarticular-Course Juvenile Idiopathic Arthritis (pJIA)
NCT01904279 ·Status: COMPLETED ·Phase: PHASE1
-
Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis
NCT02165345 ·Status: COMPLETED ·Phase: PHASE1
-
An Extension Long-Term Study of RoActemra/Actemra (Tocilizumab) in Patients With Polyarticular Juvenile Idiopathic Arthritis Who Completed The WA19977 Study
NCT01727986 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of RoActemra/Actemra and, if Initially Inadequately Responded to RoActemra/Actemra, Followed by MabThera/Rituxan in Patients With Rheumatoid Arthritis
NCT01332994 ·Status: COMPLETED ·Phase: PHASE3
-
An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies
NCT00720798 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA)
NCT01455701 ·Status: COMPLETED ·Phase: PHASE1
-
Success of Tocilizumab in RA Patients With Remission Induction and Sustained Efficacy After Discontinuation
NCT01120366 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Pharmacokinetics, Efficacy and Safety of Intravenous Golimumab in Pediatric Participants With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy
NCT02277444 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis
NCT00036374 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Tocilizumab in Patients With Active Polyarticular Juvenile Idiopathic Arthritis
NCT00988221 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Anakinra in Japanese Patients With Still's Disease (SJIA and AOSD)
NCT05814159 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Efficacy Study Of Tofacitinib In Pediatric JIA Population
NCT02592434 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis
NCT00690573 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY3337641 in Rheumatoid Arthritis
NCT02628028 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
NCT01835470 ·Status: COMPLETED ·Phase: PHASE3